| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
1,085 | 729 | 1,246 | 1,226 | 601 |
|
Cost of Revenue
|
-627 | -557 | -811 | -784 | -265 |
|
Gross Profit
|
458 | 172 | 435 | 442 | 336 |
| Selling, General and Administrative Expenses
|
-9,189 | -6,439 | -4,611 | -5,359 | -5,326 |
|
Research and Development Expenses
|
-3,170 | -4,587 | -5,201 | -8,713 | -6,450 |
| Other Income/Expense, Operating
|
133 | 133 | 339 | 272 | 105 |
|
Operating Income/Expenses
|
-12,226 | -10,893 | -9,473 | -13,800 | -11,671 |
|
Total Operating Profit/Loss
|
-11,768 | -10,721 | -9,038 | -13,358 | -11,335 |
| Total Net Finance Income/Expense
|
83 | 123 | 78 | 133 | 6 |
| Net Investment Income
|
310 | -124 | 2,925 | 4,932 | -1,091 |
| Irregular Income/Expenses
|
0 | 327 | -5,028 | 17 | -1 |
|
Other Income/Expense, Non-Operating
|
94 | 31 | 39 | 17 | 382 |
|
Non-Operating Income/Expenses, Total
|
487 | 357 | -1,986 | 5,099 | -704 |
|
Pretax Income
|
-11,281 | -10,364 | -11,024 | -8,259 | -12,039 |
|
Provision for Income Tax
|
0 | 0 | 0 | 0 | 0 |
|
Net Income from Continuing Operations
|
-11,281 | -10,364 | -11,024 | -8,259 | -12,039 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-11,281 | -10,364 | -11,024 | -8,259 | -12,039 |
|
Net Income after Non-Controlling/Minority Interests
|
-11,281 | -10,364 | -11,024 | -8,259 | -12,039 |
| Preferred/Other Stock Distribution
|
-7,645 | -6,719 | 0 | -26 | -4,450 |
|
Net Income Available to Common Stockholders
|
-18,926 | -17,083 | -11,024 | -8,285 | -16,489 |
|
Dilution to Earnings
|
1 | 0 | -291 | -5,320 | -2,807 |
|
Diluted Net Income Available to Common Stockholders
|
-18,925 | -17,083 | -11,315 | -13,605 | -19,296 |
| Basic EPS
|
-4.91 | -6.16 | -14.87 | -443.47 | -10.93k |
| Diluted EPS
|
-4.91 | -6.16 | -15.19 | -624.47 | -12.16k |
|
Basic Weighted Average Shares Outstanding
|
3,912.4330 | 2,773.5180 | 741.2500 | 18.6820 | 1.5080 |
|
Diluted Weighted Average Shares Outstanding
|
3,912.7140 | 2,773.5180 | 744.7820 | 21.7860 | 1.5870 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-11,364 | -10,487 | -11,102 | -8,392 | -12,045 |
|
EBITDA
|
-10,735 | -9,825 | -9,718 | -6,735 | -11,082 |
|
Normalized EBITDA
|
-8,614 | -7,971 | -3,482 | -12,179 | -9,621 |
12/31/2022 - 2/13/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade